A 4-month-old boy presented with symptoms and signs characteristic of infant botulism. Examination offeces revealed Clostridium botulinum type B and type B toxin. The numbers of C. botulinum and the amount of toxin in feces were measured throughout the 4-week period in hospital. The maximum numbers and amounts were detected in a fecal specimen collected 16 days after admission: this contained 8.4 x 106 C. botulinum type B colony-forming units and 61,440 mouse 100% lethal doses of type B toxin per g (wet weight) of feces. This latter figure is the highest fecal toxin titer reported yet for a case of infant botulism. By day 16, however, substantial improvement in the patient's clinical condition had occurred. This suggests that initiation of recovery from infant botulism is not necessarily preceded by a reduction in the numbers of C. botulinum organisms and the quantity of toxin in the gut.
Infant botulism results from intestinal infection with Clostridium botulinum with concomitant in vivo production of toxin (11) . Although the first laboratory-proven case is now known to have occurred in 1931 (3), infant botulism was not recognized until 1976 (8, 10) . Since then over 100 cases have been reported, mainly from the United States (1). Recently we reported the first case of infant botulism to be recognized in South Australia (4) . This case was unusual in that both C. botulinum type A and type B were isolated from the patient's feces.
Little is known of the relationship between the level of C. botulinum organisms and toxin in the gut and the clinical condition of afflicted patients. Recently, Wilcke et al. (11) determined the number of C. botulinum and other organisms in fecal samples from four cases of infant botulism, but the amount of toxin in these samples was not determined.
The present report deals with the second case of infant botulism to be recognized in South Australia, in which the quantity of C. botulinum organisms and toxin were determined in all fecal samples passed during the 4-week period that the patient was in hospital. Clinical improvement occurred before the levels of organisms and toxin in the feces reached a maximum. This suggests that recovery from infant botulism is not preceded by a reduction in the level of toxin in the gut. At the time of admission (day 1), examination revealed a very weak, severely hypotonic infant, with noisy gurgling breathing. External ocular movements were full, and the pupils showed a partial reaction to light. There was slight voluntary jaw-closure, but an absent jaw jerk. The face was mask-like and immobile, the gag reflex was absent, and there was a mild degree of pooling of secretions in the pharynx. The infant gave a weak cry in response to painful stimulation. There was complete head lag when the supine infant was lifted forward by the arms. Only slight tongue movements were observed. The limbs were weak and hypotonic, but weak voluntary movements of all extremities were present. The deep tendon reflexes were depressed, but a weak ankle jerk was preserved. The plantar responses were extensor.
On day 2 electromyography revealed a 500% in-crease in the amplitude of the compound motor action potential following 50 cycles-per-s stimulation of the left ulnar nerve. On day 6 50 cycles-per-s stimulation of the right ulnar nerve resulted in a 300% augmentation of the compound motor action potential. These electromyographic findings indicated a defect in acetyl choline release at the neuromuscular junction and, in this clinical context, strongly suggested the diagnosis of botulism. This diagnosis was confirmed by examination of feces which showed the presence of C. botulinum type B and type B toxin. Further details of microbiological findings are provided below.
Antibiotic therapy was discontinued on day 1. The child was intubated on day 2 and ventilated for 12 days. Nasogastric feeding was begun on day 4. From day 8 there was a gradual improvement in strength, with increasing voluntary activity of limbs, face, and bulbar musculature. On day 12, he was able to maintain adequate spontaneous respiration and on day 19 the endotracheal tube was removed. On day 29 tube feeding was fully replaced by breast and bottle feeding, and he was discharged from hospital. When reviewed on day 35 he still had a significant degree of generalized hypotonia, especially in the neck and trunk, with an open-hanging mouth. However, he was feeding well, with good tongue and palatal movements. He was able to use both hands to play with objects, and he was able to kick with both legs.
MATERIALS AND METHODS
Laboratory procedures. Laboratory procedures for the isolation of C. botulinum and the detection of toxin used in this study were modifications of the methods described by Hatheway (6 
RESULTS
All fecal specimens passed during the 4 weeks that the infant was in hospital were weighed and analyzed for the presence of C. botulinum organisms and toxin. If more than one stool was passed on a given day, the specimens were pooled before analysis. C. botulinum type B and type B toxin were detected, confirming the diagnosis of infant botulism. This strain of C. botulinum type B was proteolytic. Quantitative determinations were performed on all samples, and the results are shown in Table 1 .
A sample of serum collected on day 4 did not contain C. botulinum toxin in detectable amounts. A second serum sample collected during convalescence (day 47) was analyzed for the presence of antibody to type B toxin as described above. Small volumes of type B toxin were treated with the patient's serum or diluent. Two mice injected with toxin + diluent died within 36 h. Of two mice injected with toxin + serum, one died after 3.5 days and the other died after 7 days. Other serum specimens (from either the acute or convalescent stage of the illness) were not available in sufficient quantity for repetition of this test.
In an effort to determine the source of infection, garden soil and house dust samples were collected from the patient's home and examined for the presence of C. botulinum. C. botulinum type B was isolated from house dust collected by a vacuum cleaner. DISCUSSION The detection of C. botulinum type B and type B toxin in the fecal sample collected on day 1 confirmed the diagnosis of infant botulism in this case. Although the amounts of organisms and toxin in this sample were high, maximum levels were not attained until day 16, when feces contained 8.4 x 106 colony-forming units of C. botulinum and 61,440 mouse 100% lethal doses of type B toxin per g. We believe this latter figure to be the highest fecal toxin level reported for a case of infant botulism (the previous maximum report was 8, 192 mouse 100% lethal doses per g [2] ). The transient decrease in the levels of toxin and organisms during the first week of hospitalization may or may not have been due to penicillin and gentamicin therapy before admission to this hospital. It is also possible that these antibiotics may have temporarily exacerbated the paralysis. Several aminoglycosides (including gentamicin) have been shown to induce myasthenia-like syndromes (7, 9) , and penicillin also has a weak neuromuscular blocking effect (9) . In this case, however, withdrawal of antibiotic therapy as soon as botulism was suspected (day 1) did not result in early clinical improvement.
After the peak on day 16, the levels of toxin and organisms in the feces decreased rapidly and approximately followed first-order decay kinetics. Toxin and organisms were not detected after days 24 and 26, respectively. Follow-up fecal specimens, collected on days 39 and 61, were also negative for C. botulinum and toxin (results not presented). The most probable source of infection in this case was the patient's home, where C. botulinum type B was isolated from house dust.
Interestingly, there had been a marked improvement in the child's clinical condition before the level of toxin or the number of C. botulinum organisms in the feces reached their maxima. Gradual improvement in strength commenced 8 days after admission, with increasing voluntary activity of limbs, face, and bulbar musculature. By day 12 the infant was able to maintain adequate spontaneous respiration, and his bowels were functioning normally by day 16. This suggests that initiation of recovery from infant botulism is not dependent upon reduction in the amounts of C. botulinum organisms and toxin in the gut.
The reason for clinical recovery in spite of the presence of large amounts of toxin is unclear. It has been suggested that recovery might be accounted for by the production of protective antibody or cessation of absorption of toxin (1).
We were unable to demonstrate unequivocally the presence of antibody to C. botulinum type B toxin in the patient's serum. Considering the sensitivity of the technique employed, it is unlikely that significant amounts of circulating antibody were present. However, it is possible that secretory immunoglobulin A is produced in the gut and either inactivates C. botulinum toxin or prevents its absorption. Cessation of absorption of toxin in the latter stages of the illness might also result from a shift in the location of the colonizing C. botulinum to more distal regions of the gastrointestinal tract, which may be less efficient in the uptake of toxin. Comprehensive studies employing animal models of infant botulism would be required to resolve these issues.
